Company Filing History:
7 out of 31 
1 out of 107 
Years Active: 2018-2025
Title: The Innovative Mind of Ramesh Boinpally
Introduction
Ramesh Boinpally, an accomplished inventor based in Princeton, NJ, has made significant strides in the field of migraine treatment. With a total of five patents to his name, he has contributed valuable methods that aid in the acute treatment of migraine, specifically addressing various patient needs.
Latest Patents
Among his notable patents is a groundbreaking method for treating migraines with or without aura, utilizing the administration of ubrogepant. This innovative approach is particularly beneficial for patients experiencing hepatic and renal impairments, as well as those concurrently taking CYP3A4 modulators or BCRP and/or P-gp only inhibitors. The focus on individualized treatments demonstrates Boinpally's commitment to improving patient outcomes in the realm of migraine management.
Career Highlights
Ramesh Boinpally has contributed to prominent companies in the pharmaceutical sector, including Allergan Pharmaceuticals International Limited and Grünenthal GmbH. His tenure at these organizations highlights his expertise and dedication to advancing medical treatments.
Collaborations
Throughout his career, Boinpally has collaborated with talented professionals, including Joel M. Trugman and Abhijeet Jakate. Their teamwork and shared vision have undoubtedly played a role in the success of his innovative treatments.
Conclusion
Ramesh Boinpally's contributions to the field of migraine treatment, through his significant patents and collaboration with industry peers, underscore the importance of innovation in healthcare. His work continues to pave the way for more effective treatment options, enhancing the quality of life for many individuals suffering from migraines.